Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Colorcon
Chubb
Covington
Queensland Health
Teva
US Department of Justice
Cantor Fitzgerald
Dow
Mallinckrodt

Generated: January 21, 2018

DrugPatentWatch Database Preview

Sulfinpyrazone - Generic Drug Details

« Back to Dashboard

What are the generic sources for sulfinpyrazone and what is the scope of sulfinpyrazone patent protection?

Sulfinpyrazone
is the generic ingredient in two branded drugs marketed by Novartis, Barr, Ivax Pharms, Par Pharm, Vangard, and Watson Labs, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for sulfinpyrazone.
Medical Subject Heading (MeSH) Categories for sulfinpyrazone

US Patents and Regulatory Information for sulfinpyrazone

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 088933-001 Sep 6, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis ANTURANE sulfinpyrazone CAPSULE;ORAL 011556-004 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 087665-001 Sep 17, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Par Pharm SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 088934-001 Sep 6, 1985 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 087667-001 May 26, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Barr SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 087666-001 Sep 17, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Novartis ANTURANE sulfinpyrazone TABLET;ORAL 011556-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 087770-001 Nov 19, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vangard SULFINPYRAZONE sulfinpyrazone CAPSULE;ORAL 088666-001 Feb 17, 1984 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms SULFINPYRAZONE sulfinpyrazone TABLET;ORAL 087769-001 Jun 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Express Scripts
Harvard Business School
Chubb
US Army
Merck
Boehringer Ingelheim
Julphar
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot